Multiple myeloma treatment patterns and clinical outcomes in the Latin America Haemato‐Oncology (HOLA) Observational Study, 2008–2016

• Published in: British journal of haematology Vol. 188; no. 3; pp. 383 - 393
• Main Authors: Hungria, Vania Tietsche, Martínez‐Baños, Deborah M., Peñafiel, Christian R., Miguel, Carlos E., Vela‐Ojeda, Jorge, Remaggi, Guillermina, Duarte, Fernando B., Cao, Carmen, Cugliari, Maria S., Santos, Telma, Machnicki, Gerardo, Fernandez, Mariana, Grings, Mariana, Ammann, Eric M., Lin, Jennifer H., Chen, Yen‐Wen, Wong, Yu‐Ning, Barreyro, Paula
• Format: Journal Article
• Language: English
• Published: England Blackwell Publishing Ltd 01.02.2020; John Wiley and Sons Inc
• Subjects: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Autografts; Bortezomib; Bortezomib - administration & dosage; Chemotherapy; Clinical outcomes; Comorbidity; Drug Utilization - statistics & numerical data; epidemiology; Female; Follow-Up Studies; Haematological Malignancy ‐ Clinical; Hematology; Hematopoietic Stem Cell Transplantation - statistics & numerical data; Humans; Kaplan-Meier Estimate; Latin America; Latin America - epidemiology; Male; Medical records; Middle Aged; Multiple myeloma; Multiple Myeloma - epidemiology; Multiple Myeloma - therapy; Observational studies; Oncology; Patients; Practice Patterns, Physicians' - statistics & numerical data; Private Facilities - statistics & numerical data; progression‐free survival; Public Facilities - statistics & numerical data; Research Paper; Retrospective Studies; Stem cell transplantation; Thalidomide; Thalidomide - administration & dosage; Treatment Outcome; treatment patterns; Latin America; epidemiology; multiple myeloma; progression-free survival; treatment patterns; Latin America

Summary Limited data are available regarding contemporary multiple myeloma (MM) treatment practices in Latin America. In this retrospective cohort study, medical records were reviewed for a multinational cohort of 1103 Latin American MM patients (median age, 61 years) diagnosed in 2008–2015 who init...